Biogen Inc. (NASDAQ:BIIB) Receives $295.58 Average PT from Analysts

Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twenty-seven brokerages that are currently covering the firm, MarketBeat reports. Nine research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. The average 1 year price objective […]

Related Keywords

Canada ,Germany ,United States ,Erick Rowinsky ,Priya Singhal ,Cantor Fitzgerald ,Royal Bank ,Sequoia Financial Advisors ,Nasdaq ,Partners Investment Advisory ,Financial Group ,Biogen Inc ,Ballentine Partners ,Stratos Wealth Partners ,Biogen Company Profile ,Get Free Report ,Director Eric ,Wealth Partners ,Financial Advisors ,Street Partners Investment Advisory ,Get Free ,Biogen Daily ,Biogen ,Nasdaq Biib ,Biib ,Medical ,09062x10 ,Ratings ,Consensus ,